Log in to save to my catalogue

Hemolytic anemia in COVID-19

Hemolytic anemia in COVID-19

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9263052

Hemolytic anemia in COVID-19

About this item

Full title

Hemolytic anemia in COVID-19

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Annals of hematology, 2022-09, Vol.101 (9), p.1887-1895

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

COVID-19 is a global pandemic triggered by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 entry point involves the interaction with angiotensin-converting enzyme 2 (ACE2) receptor, CD147, and erythrocyte Band3 protein. Hemolytic anemia has been linked to COVID-19 through induction of autoimmune hemolytic anemia (AI...

Alternative Titles

Full title

Hemolytic anemia in COVID-19

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9263052

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9263052

Other Identifiers

ISSN

0939-5555

E-ISSN

1432-0584

DOI

10.1007/s00277-022-04907-7

How to access this item